Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AKR1B10 Antikörper (AA 76-143)

Dieser Maus Monoklonal Antikörper detektiert spezifisch AKR1B10 in WB, ELISA, IF und IHC (p). Es zeigt Reaktivität gegenüber Proben von Human. Es wurde in 8+ Publikationen zitiert.
Produktnummer ABIN566074
651,20 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für AKR1B10 Antikörper (AA 76-143) (ABIN566074)

Target

Alle AKR1B10 Antikörper anzeigen
AKR1B10 (Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))

Reaktivität

  • 43
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 39
  • 3
  • 1
Maus

Klonalität

  • 41
  • 2
Monoklonal

Konjugat

  • 23
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser AKR1B10 Antikörper ist unkonjugiert

Applikation

  • 27
  • 15
  • 10
  • 8
  • 7
  • 4
  • 4
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

1A6
  • Bindungsspezifität

    • 13
    • 5
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 76-143

    Verwendungszweck

    Mouse monoclonal antibody raised against a partial recombinant AKR1B10.

    Sequenz

    VSKLWPTFFE RPLVRKAFEK TLKDLKLSYL DVYLIHWPQG FKSGDDLFPK DDKGNAIGGK ATFLDAWE

    Kreuzreaktivität

    Human

    Produktmerkmale

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    AKR1B10 (NP_064695, 76 a.a. ~ 143 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

    Isotyp

    IgG2a
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    In 1x PBS, pH 7.4

    Handhabung

    Aliquot to avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Berard, Coombs, Severini: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).

    Matkowskyj, Bai, Liao, Zhang, Li, Rao, Omary, Yang: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." in: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).

    Chung, Matkowskyj, Li, Bai, Zhang, Tsao, Liao, Yang: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).

    Moriguchi, Zhang, Mihara, Sato: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." in: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).

    Nelson, Pillay, Henderson, Presneau, Tirabosco, Halai, Berisha, Flicek, Stemple, Stern, Wardle, Flanagan: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." in: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).

    Schmitz, Sotiropoulos, Baba, Schmid, Müller, Paul, Auer, Gamerith, Loeffler-Ragg: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).

    Bains, Grigliatti, Reid, Riggs: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." in: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).

    Satow, Shitashige, Kanai, Takeshita, Ojima, Jigami, Honda, Kosuge, Ochiya, Hirohashi, Yamada: "Combined functional genome survey of therapeutic targets for hepatocellular carcinoma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 16, Issue 9, pp. 2518-28, (2010) (PubMed).

  • Target

    AKR1B10 (Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))

    Andere Bezeichnung

    AKR1B10

    Hintergrund

    Full Gene Name: aldo-keto reductase family 1, member B10 (aldose reductase)
    Synonyms: AKR1B11,AKR1B12,ALDRLn,ARL-1,ARL1,HIS,HSI,MGC14103

    Gen-ID

    57016

    NCBI Accession

    NM_020299
Sie sind hier:
Chat with us!